Fiche de révision : Fundamentals of Infectious Disease and Antibiotics

📋 Course Outline

1. Infectious Disease Principles
2. Pathogen Transmission
3. Antibiotic Drug Classes
4. Empiric Antibiotic Therapy
5. Antibiotic Resistance Mechanisms
6. Bacterial Pathogens
7. Antibiotic Spectrum
8. Antibiotic Pharmacokinetics
9. Antibiotic Monitoring
10. Special Antibiotic Considerations

📖 1. Infectious Disease Principles

🔑 Key Concepts & Definitions

• Infectious Disease (ID): Illness caused by pathogens such as viruses, bacteria, fungi, protozoa, parasites, or infectious proteins (prions). Transmitted via contact, ingestion, airborne droplets, or vectors.

• Pathogen: Microorganism capable of causing disease; includes bacteria, viruses, fungi, protozoa, parasites, and prions.

• Contagious (Communicable) Disease: Infectious diseases transmitted directly from person to person through contact, droplets, or vectors.

• Empiric Therapy: Initial broad-spectrum antimicrobial treatment started before pathogen identification, guided by clinical judgment and local resistance patterns.

• Antibiogram: A chart summarizing antimicrobial susceptibility data from isolates over a specific period, guiding empiric antibiotic selection.

• Antibiotic Resistance: The ability of bacteria to grow in the presence of antibiotics that would normally inhibit or kill them, caused by intrinsic resistance, selection pressure, acquired resistance genes, or enzymatic degradation.

📝 Essential Points

• Infectious diseases involve complex interactions between pathogen, drug, and host; all must be considered for effective treatment.

• Transmission mechanisms include contact, ingestion, airborne droplets, and vectors; understanding these helps in prevention and control.

• Empiric antibiotic choice relies on infection site, likely organism, local resistance patterns, and patient factors; once culture results are available, therapy should be streamlined to narrow-spectrum agents.

• Gram stain provides rapid preliminary identification of organisms based on cell wall properties and shape, guiding initial therapy.

• Resistance mechanisms include enzymatic degradation (e.g., beta-lactamases), efflux pumps, altered target sites, and permeability changes; these influence antibiotic effectiveness.

• Multidrug-resistant organisms (MDROs) such as MRSA, ESBL-producing Enterobacteriaceae, and CRE pose significant treatment challenges, often requiring combination therapy or last-line agents like polymyxins.

• Antibiotic stewardship programs aim to optimize antimicrobial use, reduce resistance, and improve patient outcomes through guidelines, audits, and education.

💡 Key Takeaway

Effective management of infectious diseases hinges on understanding pathogen characteristics, resistance mechanisms, and patient factors, with a focus on targeted therapy and antimicrobial stewardship to combat resistance and improve outcomes.

📖 2. Pathogen Transmission

🔑 Key Concepts & Definitions

• Infectious Disease (ID): Illness caused by pathogens such as viruses, bacteria, fungi, protozoa, parasites, or infectious proteins (prions).
• Pathogen: Microorganism capable of causing disease in a host. Includes viruses, bacteria, fungi, protozoa, parasites, and prions.
• Transmission Mechanisms: Ways pathogens spread from one host to another, including contact, ingestion, airborne droplets, and vectors.
• Contagious (Communicable) Diseases: Infectious diseases that spread directly or indirectly from person to person.
• Airborne Transmission: Spread of pathogens via droplets or aerosols suspended in the air, e.g., influenza, tuberculosis.
• Vector-borne Transmission: Spread through carriers like mosquitoes, ticks, or other arthropods, e.g., malaria, Lyme disease.

📝 Essential Points

• Pathogens are transmitted through various mechanisms: physical contact, contaminated food/water, contact with contaminated objects, airborne droplets, and vectors.
• The infectiousness depends on pathogen type, host immunity, and environmental factors.
• Transmission routes influence infection control strategies: hand hygiene, protective equipment, vector control, and sanitation.
• Diseases are classified as contagious if they spread easily from person to person, requiring specific precautions.
• Recognizing transmission mechanisms helps in selecting appropriate prophylaxis, treatment, and prevention measures.
• Understanding the difference between airborne, droplet, contact, and vector transmission is crucial for infection control in healthcare and community settings.

💡 Key Takeaway

Pathogen transmission occurs through diverse mechanisms, and understanding these routes is essential for effective disease prevention, control, and treatment strategies.

📖 3. Antibiotic Drug Classes

🔑 Key Concepts & Definitions

• Antibiotic Class: A group of antibiotics sharing similar chemical structures, mechanisms of action, and spectrum of activity (e.g., beta-lactams, aminoglycosides).

• Broad-spectrum Antibiotics: Drugs effective against a wide variety of bacteria, covering both gram-positive and gram-negative organisms (e.g., carbapenems, third-generation cephalosporins).

• Narrow-spectrum Antibiotics: Drugs targeting specific bacteria or groups, minimizing impact on normal flora (e.g., penicillin G for streptococci).

• Bactericidal: Antibiotics that kill bacteria directly, usually by disrupting cell walls or DNA (e.g., beta-lactams, aminoglycosides).

• Bacteriostatic: Antibiotics that inhibit bacterial growth, relying on immune system to clear infection (e.g., tetracyclines, macrolides).

• Mechanism of Action: The specific target or process in bacteria that an antibiotic affects, such as cell wall synthesis, protein synthesis, DNA replication, or folic acid synthesis.

📝 Essential Points

• Drug Mechanisms:

  • Cell Wall Inhibitors: Beta-lactams (penicillins, cephalosporins, carbapenems), glycopeptides (vancomycin).
  • Protein Synthesis Inhibitors: Macrolides, tetracyclines, aminoglycosides, clindamycin.
  • Nucleic Acid Synthesis Inhibitors: Quinolones (DNA gyrase/topoisomerase IV inhibitors), metronidazole.
  • Folic Acid Synthesis Inhibitors: Sulfonamides, trimethoprim.

• Spectrum of Activity:

  • Beta-lactams: Variable; penicillins mainly gram-positive, carbapenems broader.
  • Aminoglycosides: Primarily gram-negative, bactericidal.
  • Macrolides: Mainly gram-positive and atypicals.
  • Tetracyclines: Broad, including atypicals and some gram-positive.

• Resistance Mechanisms:

  • Production of beta-lactamases.
  • Alteration of drug target sites.
  • Efflux pumps removing antibiotics.
  • Enzymatic degradation of antibiotics.

• Pharmacokinetics:

  • Hydrophilic drugs (e.g., aminoglycosides) have limited tissue penetration but are renally eliminated.
  • Lipophilic drugs (e.g., macrolides) penetrate tissues well and are metabolized hepatically.

• Therapeutic Considerations:

  • Use narrow-spectrum agents when possible to reduce resistance.
  • Adjust dosing based on pharmacokinetics and site of infection.
  • Be aware of potential resistance and cross-reactivity (e.g., penicillin allergy).

💡 Key Takeaway

Antibiotic classes are categorized by their chemical structure and mechanism of action, which determine their spectrum, bactericidal or bacteriostatic effects, and resistance patterns; understanding these helps optimize antimicrobial therapy and combat resistance.

📖 4. Empiric Antibiotic Therapy

🔑 Key Concepts & Definitions

• Empiric Antibiotic Therapy: Initiation of antibiotics based on the most probable pathogens and infection site before specific microbiological results are available. It aims to cover likely organisms to prevent disease progression.

• Broad-spectrum Antibiotics: Drugs effective against a wide range of bacteria, used initially in empiric therapy to cover multiple potential pathogens. Examples include carbapenems and third-generation cephalosporins.

• Culture and Susceptibility Testing (C&S): Laboratory procedures to identify causative organisms and determine their antibiotic sensitivities, guiding targeted therapy and de-escalation.

• Antibiogram: A cumulative report of antimicrobial susceptibilities of local bacterial isolates over a specific period, used to inform empiric therapy choices based on local resistance patterns.

• Minimum Inhibitory Concentration (MIC): The lowest concentration of an antibiotic that inhibits visible bacterial growth. Susceptibility is interpreted based on MIC values relative to established breakpoints.

• De-escalation: The process of narrowing antibiotic therapy once microbiological results are available to minimize resistance development and adverse effects.

📝 Essential Points

• Empiric therapy is initiated based on infection site, suspected pathogens, patient factors, and local resistance patterns, often guided by antibiograms.

• Initial broad-spectrum antibiotics should be chosen carefully to maximize coverage while minimizing unnecessary exposure.

• Microbiological samples (e.g., blood, urine, tissue) should be obtained before starting antibiotics to facilitate targeted therapy.

• Once culture results are available, therapy should be streamlined to the narrowest effective agent to reduce resistance and toxicity.

• Consider patient-specific factors such as allergies, renal/hepatic function, comorbidities, and risk for resistant organisms when selecting antibiotics.

• Antibiotic resistance mechanisms include intrinsic resistance, selection pressure, acquired resistance, and enzymatic degradation, complicating treatment.

• Monitoring patient response and adjusting therapy accordingly is critical for successful outcomes.

💡 Key Takeaway

Empiric antibiotic therapy aims to promptly cover likely pathogens based on infection site and local resistance patterns, but should be refined with microbiological data to optimize efficacy and reduce resistance development.

📖 5. Antibiotic Resistance Mechanisms

🔑 Key Concepts & Definitions

• Intrinsic Resistance: Natural, inherent resistance of a bacterial species to certain antibiotics due to structural or functional characteristics.
  Example: E. coli's resistance to vancomycin because its cell wall is too large for the antibiotic to penetrate.

• Selection Pressure: The process by which antibiotic use kills susceptible bacteria, allowing resistant strains to survive and proliferate, leading to increased resistance over time.

• Acquired Resistance: Resistance gained through horizontal gene transfer or mutation, enabling bacteria to survive antibiotics they were previously susceptible to.
  Mechanisms include: plasmid transfer, transposons, or gene mutation.

• Antibiotic Degradation: Resistance mechanism where bacteria produce enzymes (e.g., beta-lactamases) that chemically break down antibiotics before they reach their target.

• Beta-lactamases & ESBLs: Enzymes that hydrolyze beta-lactam antibiotics; Extended-spectrum beta-lactamases (ESBLs) can inactivate most penicillins and cephalosporins, complicating treatment.

• Carbapenem-Resistant Enterobacteriaceae (CRE): Multidrug-resistant gram-negative bacteria producing enzymes (e.g., carbapenemases) that hydrolyze carbapenems, often requiring combination therapy with high-toxicity drugs.

📝 Essential Points

• Resistance can be intrinsic (natural) or acquired via genetic exchange or mutation.
• Antibiotic use exerts selection pressure, promoting resistant strains.
• Bacteria produce enzymes like beta-lactamases to degrade antibiotics, rendering them ineffective.
• ESBLs and carbapenemases are significant resistance enzymes that limit treatment options.
• Multidrug-resistant organisms (e.g., MRSA, VRE, ESBL producers, CRE) pose major treatment challenges.
• Resistance mechanisms include altered target sites, reduced drug uptake, and efflux pumps that expel antibiotics.

💡 Key Takeaway

Antibiotic resistance arises through natural or acquired mechanisms that bacteria use to evade antimicrobial effects, making infections harder to treat and emphasizing the importance of stewardship and targeted therapy.

📖 6. Bacterial Pathogens

🔑 Key Concepts & Definitions

• Pathogen: A microorganism capable of causing disease in a host, including bacteria, viruses, fungi, protozoa, parasites, and infectious proteins (prions).

• Bacterial Pathogen: A specific type of pathogen that is a bacteria capable of infecting tissues and causing disease, such as Streptococcus pneumoniae or Escherichia coli.

• Infection Site: The specific anatomical location where bacteria invade and multiply, e.g., respiratory tract, skin, urinary tract.

• Multidrug-Resistant (MDR) Bacteria: Bacteria resistant to multiple classes of antibiotics, complicating treatment; examples include MRSA and ESBL-producing Klebsiella pneumoniae.

• Gram Stain: A laboratory technique classifying bacteria into Gram-positive (purple) or Gram-negative (pink) based on cell wall properties, guiding initial therapy.

• Virulence Factors: Molecules produced by bacteria that enhance their ability to cause disease, such as toxins, adhesion molecules, and enzymes.

📝 Essential Points

• Infectious diseases are caused by various pathogens, with bacteria being a primary focus in bacterial infections.

• Transmission mechanisms include contact, ingestion, airborne droplets, and vectors; understanding transmission helps in prevention.

• Empiric antibiotic therapy relies on recognizing common bacteria associated with infection sites, guided by local resistance patterns and Gram stain results.

• Antibiotic susceptibility testing (via culture and antibiogram) determines effective drugs, with MIC values indicating bacterial sensitivity or resistance.

• Resistance mechanisms include intrinsic resistance, selection pressure, acquired resistance genes, and enzymatic degradation (e.g., beta-lactamases).

• Key resistant bacteria include MRSA, VRE, ESBL-producing E. coli, Klebsiella, and carbapenem-resistant organisms like A. baumannii.

• Proper antibiotic selection involves considering the pathogen, site of infection, patient factors, and resistance patterns to optimize outcomes and reduce resistance development.

💡 Key Takeaway

Understanding bacterial pathogens, their resistance mechanisms, and susceptibility patterns is essential for effective treatment and combating antibiotic resistance in infectious diseases.

📖 7. Antibiotic Spectrum

🔑 Key Concepts & Definitions

• Spectrum of Activity: The range of bacteria or pathogens that an antibiotic can effectively target and inhibit or kill. It can be broad (effective against many bacteria) or narrow (targeting specific bacteria).

• Broad-spectrum Antibiotics: Drugs that act against a wide variety of bacteria, including both Gram-positive and Gram-negative organisms. Used empirically when the pathogen is unknown.

• Narrow-spectrum Antibiotics: Drugs that target specific bacteria or groups of bacteria, minimizing impact on normal flora and reducing resistance development. Used once the pathogen is identified.

• Empiric Therapy: Initial antibiotic treatment based on the likely pathogens and local resistance patterns, started before definitive microbiological results are available.

• Targeted Therapy: Antibiotic treatment tailored to the specific pathogen identified by culture and susceptibility testing, often involving narrow-spectrum agents.

• Resistance and Susceptibility: The ability of bacteria to withstand antibiotic effects, which can be intrinsic or acquired. Susceptibility indicates the bacteria can be inhibited or killed by the antibiotic at standard doses.

📝 Essential Points

• Antibiotics are classified by their spectrum: broad or narrow, which guides initial empiric therapy and subsequent de-escalation.
• Empiric therapy should consider likely pathogens, infection site, patient factors, and local resistance patterns (antibiogram).
• Culture and susceptibility testing refine therapy, allowing for narrowing the spectrum to reduce resistance and adverse effects.
• Resistance mechanisms (e.g., beta-lactamases, ESBLs, carbapenemases) influence the choice of antibiotics, especially in multidrug-resistant organisms.
• The spectrum of antibiotics varies by drug class, with beta-lactams, aminoglycosides, macrolides, tetracyclines, and others each having characteristic activity profiles.
• Knowledge of the pathogen's susceptibility and the antibiotic's spectrum is critical for effective and safe treatment.

💡 Key Takeaway

Understanding the spectrum of antibiotics is essential for selecting appropriate empiric and targeted therapies, minimizing resistance, and optimizing patient outcomes.

📖 8. Antibiotic Pharmacokinetics

🔑 Key Concepts & Definitions

• Pharmacokinetics (PK): The study of how drugs move through the body, including absorption, distribution, metabolism, and excretion (ADME).
• Absorption: The process by which an antibiotic enters the bloodstream from the site of administration (e.g., oral, IV).
• Distribution: The dispersion of the antibiotic throughout body tissues and fluids, influenced by drug properties like lipophilicity and protein binding.
• Metabolism: The chemical alteration of the antibiotic, primarily in the liver, affecting its activity and elimination.
• Excretion: The removal of the antibiotic from the body, mainly via renal or hepatic pathways.
• Concentration-dependent killing: Antibiotics (e.g., aminoglycosides, fluoroquinolones) that kill bacteria more effectively at higher drug concentrations.
• Time-dependent killing: Antibiotics (e.g., beta-lactams) that are most effective when drug levels stay above the minimum inhibitory concentration (MIC) for a certain period.

📝 Essential Points

• Drug properties: Hydrophilic antibiotics (e.g., beta-lactams) tend to have limited tissue penetration but are cleared rapidly via kidneys; lipophilic antibiotics (e.g., macrolides) penetrate tissues well and have longer half-lives.
• Dosing strategies: Concentration-dependent antibiotics are dosed less frequently with higher doses; time-dependent antibiotics require frequent dosing or continuous infusion to maintain levels above MIC.
• Bioavailability: The proportion of an oral drug that reaches systemic circulation; critical for choosing oral vs. IV therapy.
• Distribution factors: Volume of distribution (Vd) influences how widely an antibiotic spreads; high Vd indicates extensive tissue penetration.
• Renal clearance: Many antibiotics are eliminated via the kidneys; renal function (e.g., creatinine clearance) guides dosing adjustments.
• Therapeutic drug monitoring (TDM): Used for drugs like vancomycin and aminoglycosides to optimize efficacy and minimize toxicity.

💡 Key Takeaway

Understanding the pharmacokinetic principles of antibiotics enables tailored dosing to maximize bacterial eradication while minimizing toxicity, considering drug properties, infection site, and patient-specific factors.

📖 9. Antibiotic Monitoring

🔑 Key Concepts & Definitions

• Empiric Therapy: Initiation of antibiotics based on the most likely pathogens before culture results are available, often broad-spectrum to cover multiple organisms.

• Culture & Susceptibility Testing: Laboratory process to identify causative bacteria and determine which antibiotics inhibit their growth, guiding targeted therapy.

• Minimum Inhibitory Concentration (MIC): The lowest concentration of an antibiotic that prevents visible bacterial growth; used to interpret susceptibility.

• Antibiogram: A cumulative report of antimicrobial susceptibilities of local bacterial isolates over a specific period, informing empiric antibiotic choices.

• Antibiotic Resistance: The ability of bacteria to grow despite the presence of antibiotics that typically inhibit or kill them, caused by mechanisms like enzyme degradation or gene transfer.

• Antimicrobial Stewardship Programs (ASPs): Coordinated efforts to optimize antibiotic use, reduce resistance, and improve patient outcomes through guidelines, audits, and education.

📝 Essential Points

• Antibiotic selection depends on infection site, likely pathogens, severity, resistance patterns, and patient factors (age, allergies, organ function).

• Empiric therapy is often broad but should be streamlined to narrow-spectrum antibiotics once culture results are available to minimize resistance.

• Gram stain results provide rapid preliminary identification, guiding initial empiric therapy before definitive culture data.

• Resistance mechanisms include intrinsic resistance, selection pressure, acquired resistance genes, and enzymatic degradation (e.g., beta-lactamases, ESBLs, carbapenemases).

• Key resistant pathogens include ESBL-producing Enterobacteriaceae, MRSA, VRE, and carbapenem-resistant organisms, requiring specific antibiotic strategies.

• Antibiotic stewardship involves monitoring antibiotic use, adjusting therapy based on microbiology results, and avoiding unnecessary prolonged courses to prevent CDI and resistance.

💡 Key Takeaway

Effective antibiotic monitoring combines rapid diagnostics, susceptibility testing, and stewardship principles to optimize treatment, combat resistance, and improve patient outcomes.

📖 10. Special Antibiotic Considerations

🔑 Key Concepts & Definitions

• Empiric Therapy: Initiation of broad-spectrum antibiotics before pathogen identification, based on clinical suspicion and local resistance patterns.
• Antibiogram: A cumulative report of antimicrobial susceptibilities of bacteria isolated from a specific institution over a period, guiding empiric therapy.
• Gram Stain: A rapid laboratory technique that classifies bacteria as Gram-positive (purple) or Gram-negative (pink) based on cell wall properties, aiding initial diagnosis.
• Antibiotic Resistance: The ability of bacteria to grow despite the presence of antibiotics that normally inhibit or kill them, often due to genetic mechanisms like beta-lactamase production.
• Synergy: The combined effect of two antibiotics that exceeds the sum of their individual effects, often used to treat complex infections (e.g., beta-lactam + aminoglycoside).
• Antimicrobial Stewardship: Programs aimed at optimizing antibiotic use to improve patient outcomes, reduce resistance, and minimize adverse effects through guidelines, audits, and education.

📝 Essential Points

• Selection Factors: Antibiotic choice depends on infection site, likely organism, severity, resistance risk, patient factors (age, allergies, renal/hepatic function), and local resistance data.
• Empiric to Targeted Therapy: Start broad, then narrow based on culture and susceptibility results, ideally switching to the most specific, effective, and narrow-spectrum agent.
• Resistance Mechanisms: Bacteria may resist via intrinsic resistance, acquired resistance (gene transfer), or enzymatic degradation (e.g., beta-lactamases, ESBLs, carbapenemases).
• Multidrug-Resistant Organisms (MDROs): Pathogens like MRSA, VRE, ESBL-producing Enterobacteriaceae, and CRE require special antibiotics and combination therapy, often with higher toxicity risks.
• Clostridioides difficile (C. diff): Antibiotics disrupting gut flora (e.g., broad-spectrum penicillins, cephalosporins, quinolones) can lead to CDI; minimizing unnecessary use reduces risk.
• Antimicrobial Stewardship: Critical for reducing resistance, involves monitoring prescribing habits, supporting appropriate dosing, duration, and de-escalation strategies.

💡 Key Takeaway

Effective antibiotic use hinges on understanding pathogen susceptibility, resistance mechanisms, and patient-specific factors, with stewardship programs essential to combat resistance and optimize outcomes.

📊 Synthesis Tables

⚠️ Common Pitfalls & Confusions

1. Confusing bactericidal and bacteriostatic effects; some antibiotics (e.g., aminoglycosides) are bactericidal, while others (e.g., tetracyclines) are bacteriostatic.
2. Assuming broad-spectrum antibiotics are always preferable; overuse promotes resistance.
3. Misinterpreting the spectrum of antibiotics; e.g., believing all beta-lactams cover atypicals.
4. Overlooking pharmacokinetics when selecting antibiotics for tissue penetration.
5. Ignoring local resistance patterns (antibiogram) in empiric therapy.
6. Failing to de-escalate therapy after pathogen identification.
7. Confusing mechanisms of resistance; e.g., beta-lactamase production vs. target site alteration.
8. Underestimating the importance of dosing adjustments in renal/hepatic impairment.
9. Mistaking false friends in foreign language (if applicable); e.g., "sensible" vs. "sensitive" in antibiotic susceptibility.

✅ Exam Checklist

• Define infectious disease and pathogen.
• List transmission mechanisms and their implications.
• Differentiate between contagious and non-contagious diseases.
• Explain the purpose and principles of empiric antibiotic therapy.
• Identify common antibiotic classes and their mechanisms of action.
• Describe spectrum (broad vs. narrow) and bactericidal vs. bacteriostatic effects.
• Recognize key resistance mechanisms, including beta-lactamases and efflux pumps.
• Understand pharmacokinetic considerations for antibiotic selection.
• Know the importance of antibiotic susceptibility testing and antibiograms.
• Outline principles of antibiotic stewardship and de-escalation.
• Describe common bacterial pathogens and their typical susceptibilities.
• Recognize special considerations for antibiotics (e.g., toxicity, monitoring).
• Confirm mastery of key vocabulary and concepts related to antibiotics and transmission.